Use of molecular resistance assays to provide alterative oral treatment strategies for gonorrhoea in Indigenous and other high-risk populations; a randomised cluster trial [ 2017 - 2020 ]

Research Grant

Researchers: A/Pr David Whiley (Principal investigator) ,  A/Pr James Ward ,  A/Pr Marcus Chen ,  A/Pr Rebecca Guy ,  Dr Handan Wand
View all 9 related researchers

Brief description Gonorrhoea has now developed resistance to almost all antibiotics that have been used to treat it. In this study, we will investigate a new treatment approach that selects antibiotics on a patient-by-patient basis. We will use new molecular assays to first test if a gonorrhoea strain infecting a patient is susceptible to an antibiotic, and will then treat on the basis of this result. By doing so, we will optimize our use of antibiotics and improve treatment strategies for gonorrhea.

Funding Amount $AUD 850,507.04

Funding Scheme Project Grants

Notes Standard Project Grant